These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 6345031

  • 1. In vitro proliferative response to M. leprae and PPD of isolated T cell subsets from leprosy patients.
    Bach MA, Wallach D, Flageul B, Cottenot F.
    Clin Exp Immunol; 1983 Apr; 52(1):107-14. PubMed ID: 6345031
    [Abstract] [Full Text] [Related]

  • 2. M. leprae and PPD-triggered T cell lines in tuberculoid and lepromatous leprosy.
    Shankar P, Agis F, Wallach D, Flageul B, Cottenot F, Augier J, Bach MA.
    J Immunol; 1986 Jun 01; 136(11):4255-63. PubMed ID: 2422278
    [Abstract] [Full Text] [Related]

  • 3. Mechanisms of T-cell unresponsiveness in leprosy.
    Bach MA, Hoffenbach A, Lagrange PH, Wallach D, Cottenot F.
    Ann Immunol (Paris); 1983 Jun 01; 134D(1):75-84. PubMed ID: 6226239
    [Abstract] [Full Text] [Related]

  • 4. In vitro lymphocyte stimulation in patients with lepromatous and borderline tuberculoid leprosy. The effect of dapsone treatment on the response to Mycobacterium leprae antigens, tuberculin purified protein derivative and non-mycobacterial stimulants.
    Reitan LJ, Closs O, Belehu A.
    Int J Lepr Other Mycobact Dis; 1982 Dec 01; 50(4):455-67. PubMed ID: 6763003
    [Abstract] [Full Text] [Related]

  • 5. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients.
    Mutis T, Kraakman EM, Cornelisse YE, Haanen JB, Spits H, De Vries RR, Ottenhoff TH.
    J Immunol; 1993 May 15; 150(10):4641-51. PubMed ID: 8482851
    [Abstract] [Full Text] [Related]

  • 6. Restoration of proliferative response to M. leprae antigens in lepromatous T cells against candidate antileprosy vaccines.
    Mustafa AS.
    Int J Lepr Other Mycobact Dis; 1996 Sep 15; 64(3):257-67. PubMed ID: 8862259
    [Abstract] [Full Text] [Related]

  • 7. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
    Shinde SR, Chiplunkar SV, Butlin R, Samson PD, Deo MG, Gangal SG.
    Int J Lepr Other Mycobact Dis; 1993 Mar 15; 61(1):51-8. PubMed ID: 8326181
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Mycobacterium leprae antigen-induced suppression of T cell proliferation in vitro.
    Kaplan G, Gandhi RR, Weinstein DE, Levis WR, Patarroyo ME, Brennan PJ, Cohn ZA.
    J Immunol; 1987 May 01; 138(9):3028-34. PubMed ID: 3106496
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Limiting dilution analysis of the human T cell response to mycobacterial antigens from BCG vaccinated individuals and leprosy patients.
    Brett SJ, Kingston AE, Colston MJ.
    Clin Exp Immunol; 1987 Jun 01; 68(3):510-20. PubMed ID: 3308217
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. T-cell responses of leprosy patients and healthy contacts toward separated protein antigens of Mycobacterium leprae.
    Gulle H, Schoel B, Chiplunkar S, Gangal S, Deo MG, Kaufmann SH.
    Int J Lepr Other Mycobact Dis; 1992 Mar 01; 60(1):44-53. PubMed ID: 1602193
    [Abstract] [Full Text] [Related]

  • 14. Defective cell-mediated immunity in leprosy: failure of T cells from lepromatous leprosy patients to respond to Mycobacterium leprae is associated with defective expression of interleukin 2 receptors and is not reconstituted by interleukin 2.
    Mohagheghpour N, Gelber RH, Larrick JW, Sasaki DT, Brennan PJ, Engleman EG.
    J Immunol; 1985 Aug 01; 135(2):1443-9. PubMed ID: 2989366
    [Abstract] [Full Text] [Related]

  • 15. Effect of Mycobacterium leprae on lymphocyte proliferation: suppression of mitogen and antigen responses of human peripheral blood mononuclear cells.
    Touw J, Stoner GL, Belehu A.
    Clin Exp Immunol; 1980 Sep 01; 41(3):397-405. PubMed ID: 6449337
    [Abstract] [Full Text] [Related]

  • 16. Lymphocyte response of leprosy patients to human-derived and purified armadillo-derived Mycobacterium leprae, BCG and PPD.
    Smelt AH, Liew FY, Rees RJ.
    Clin Exp Immunol; 1978 Nov 01; 34(2):164-9. PubMed ID: 367652
    [Abstract] [Full Text] [Related]

  • 17. In vivo responses to Mycobacterium leprae: antigen presentation, interleukin-2 production, and immune cell phenotypes in naturally occurring leprosy lesions.
    Longley J, Haregewoin A, Yemaneberhan T, Warndorff van Diepen T, Nsibami J, Knowles D, Smith KA, Godal T.
    Int J Lepr Other Mycobact Dis; 1985 Sep 01; 53(3):385-94. PubMed ID: 3900245
    [Abstract] [Full Text] [Related]

  • 18. Thalidomide does not modify the ability of cells in leprosy patients to incorporate [3H]-thymidine when incubated with M. leprae antigens.
    Tadesse A, Taye E, Sandoval F, Shannon EJ.
    Lepr Rev; 2003 Sep 01; 74(3):206-14. PubMed ID: 14577465
    [Abstract] [Full Text] [Related]

  • 19. Evidence for the presence of M. leprae reactive T lymphocytes in patients with lepromatous leprosy.
    Nath I, Sathish M, Jayaraman T, Bhutani LK, Sharma AK.
    Clin Exp Immunol; 1984 Dec 01; 58(3):522-30. PubMed ID: 6391762
    [Abstract] [Full Text] [Related]

  • 20. Interleukin-2-induced T-cell response to M. leprae in lepromatous leprosy: reversion of a suppressor mechanism or expansion of a small M. leprae-reactive T-cell pool?
    Shankar P, Wallach D, Bach MA.
    Int J Lepr Other Mycobact Dis; 1985 Dec 01; 53(4):649-52. PubMed ID: 2935587
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.